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Stephanie I. Savino
Abstract
Pyrethroid insecticides have been used for more than 40 years and account for 25% of the
global insecticide market. With increasing use of pyrethroids over recent years, human exposure
to these chemicals is more likely. Because of the assumed harmless effects of their use,
pyrethroids have grown to become the major class of pesticides for household, agricultural and
public health applications worldwide. The acute toxicity of pyrethroids to adults has been welldocumented by the U.S. Environmental Protection Agency as moderately toxic to mammals.
However, there is little evidence regarding the potential toxicological effects of the chemicals on
mammalian neurodevelopment. Recent publications suggest that pyrethroids inhibit neurite
outgrowth in PC12 cells; however there is limited information available that has examined this
phenomena on mammalian neurons.
In the current study, we aim to develop a neurodevelopment assay that could be utilized
to investigate the effects of pyrethroids on the development of neuronal cells from
undifferentiated neocortical cells cultured from the embryonic Mus musculus brain. Throughout
the 14 day culture, the differentiation of the mouse neocortical cells into neurons were monitored
with fluorescent microscopy and measured via percent differentiated calculations. The results of
this study revealed that neurite outgrowth begins at day eight of culture, and maximum
differentiation of the cells into neurons occurred at day 14 of the culture, with a percent
differentiation of 64.8%. It is predicted that future pyrethroid exposure of these differentiated
cells will inhibit neuronal differentiation in correlation to this timeline, with maximum inhibition
of differentiation occurring at the fourteenth day of growth for this particular culture timeline.
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This evidence would suggest that these compounds may act as developmental neurotoxicants in
mammals.

Page 3 of 26

Savino

Introduction
Pyrethroid insecticides have been used for more than 40 years and account for 25% of the
global insecticide market (Shafer et al., 2005). Both the naturally occurring pyrethrins isolated
from the plant genus Chrysanthemum (Tran et al., 2006) and their synthetic equivalents the
pyrethroids are potent and effective insecticides to which significant amount of human exposure
is attributed. However, with few reports of human fatalities in regard to these chemicals,
mammals have been found to be approximately three times less sensitive than insects to the toxic
effects of the pyrethroids due to a faster rate of metabolic disposal of the chemicals from the
body, and a much higher body temperature (Ray and Fry, 2006). Because of the assumed
harmless effects of their use, pyrethroids have grown to become the major class of pesticides
used for household, agricultural and public health applications worldwide.
Pyrethroids are one of the most popular pesticides used across the globe today, and their
popularity is continuing to grow. To date, there are 16 pyrethroids registered for legal use in the
United States alone in both agricultural and everyday consumer products (Bryant and Bite,
2003). These increasing opportunities for chemical exposure have raised doubt as to whether or
not the pyrethroids are actually safe to man. As a number of recent publications have suggested
that potential effects of these synthetic pesticides not considered in their original investigations
may be pivotal for human health, it is necessary that new studies be conducted in a more accurate
evaluation of these chemicals.
The acute toxicity of pyrethroids to adults has been well-documented, and the U.S.
Environmental Protection Agency has documented them as moderately toxic (EPA Category II)
to mammals (Soderlund et al., 2002). Despite the abundance of this information, there is little to
no evidence regarding the potential effects of the chemicals on the neurodevelopment of
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mammals. Under the Food Quality Protection Act of 1996, the U.S. Environmental Protection
Agency (EPA) has been required to assess all potential risks that might be associated with any
mammal that might be subjected to experiencing contact with the chemicals from either
agricultural or consumer applications of the product (Shafer et al., 2005). Following a thorough
assessment, the EPA is required to include a safety factor in evaluating the potential risk against
developing individuals to the toxicity of the pesticides (Shafer et al., 2005).
The general unanimity of the few studies that are available that have aimed to investigate
the potential detrimental effects of the pesticides on developing individuals have found that the
extent of the age-related toxicity by the pyrethroids appears to be much larger than other classes
of pesticides, regardless of use of type I or type II pyrethroid compounds. In a 1994 study with
weanling and adult rats, 11 day-old weanling rats were observed to be 16 times more sensitive
than adults to acute lethality to the type II pyrethroid deltamethrin, and 21 day-old rats were 7
times more sensitive than adults to acute lethality to deltamethrin (Sheets et al., 1994). The
results of this study demonstrated that there is a large age dependence on the acute toxicity of
pyrethroids to developing rats, which have lower metabolic capabilities than adult rats.
Though this general conclusion has been made, a safety factor can be included in the
EPA evaluation only if significant scientific data exists regarding which possible effects the
synthetic insecticides may have on developing mammals in regard to the developmental
neurotoxicity (Shafer et al., 2005). Since there are very minimal amounts of studies that have
been conducted to evaluate the effects of the pyrethroids on the developmental neurotoxicity of
neonates, the current study aims is one small step toward this goal.
In the current study, a neurodevelopment assay was evaluated for the development of
neuronal cells from undifferentiated neocortical cells cultured from the embryonic Mus musculus
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brain. The neocortical cells were maintained in a fourteen-day culture, and the differentiation of
the cells into neurons were monitored with fluorescent microscopy and measured via percent
differentiated calculations. We hypothesize that cell differentiation into neurons will begin at day
ten of the culture, and maximum differentiation will be at day fourteen of the culture. In future
study, this neurodevelopment assay will be used to evaluate the potentially detrimental effects of
the pyrethroids on developing neurons to investigate whether or not these compounds may also
act as developmental neurotoxicants in mammals.

Materials and Methods
Embryonic mouse cortical tissue was purchased from BrainBits, LLC (Springfield, IL,
USA). Prolong Gold antifade reagent with DAPI was purchased from Invitrogen (Grand Island,
NY, USA). Anti-Neuron specific beta III Tubulin antibody [2G10] - Neuronal Marker was
purchased from Abcam, PLC (Cambridge, MA, USA). Anti-mouse IgG secondary antibody
conjugated to Alexa Fluor 488 was purchased from Invitrogen (Grand Island, NY, USA). All
other reagents and chemicals were purchased from Sigma-Aldrich, Co., LLC (St. Louis, MO,
USA).
Preparation of Poly-D-Lysine Coverslips
Small, round glass coverslips were obtained and placed in a 24-well cell culture plate.
Aliquots of 100 µl of Poly-D-Lysine solution were added to each coverslip. The Poly-D-Lysine
solution was allowed to incubate and dry to coverslips for 2 hours at 25°C under a hood. Once
incubation time had elapsed, any remaining Poly-D-Lysine which had not dried to coverslips was
removed and discarded. Each coverslip was then washed with 1000 µl of sterile H2O and were
air dried.
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Neocortical Cell Culturing
Papain buffer (100 µl papain enzyme: 400 µl buffer) was incubated in a 30°C water bath
for 30 minutes. Two hundred and fifty µl of the papain buffer was transferred to a centrifuge
tube containing 400 µl Hibernate-A-CaCl2™. The neocortical tissue medium was removed from
its container and moved to a separate centrifuge tube for temporary storage. The mixture of
papain buffer and Hibernate-A-CaCl2™ solution was then transferred into the container
containing the neocortical tissue. The cortex tissue was incubated in this solution at 30°C for 30
minutes. When tissue pieces were settled at the bottom of the container, all solution was removed
from the tissue and considered waste. The cortex tissue was then resuspended in 1 ml of its
original medium and gently titrated via use of a 200 µl pipette. The remaining medium was then
added to the titrated tissue. The container containing the titrated tissue was then set aside for a
brief time as to allow any tissue pieces to settle to the bottom of the container. The titrated
solution was then transferred into a 15 ml conical vial. The solution was centrifuged at 200 x g
for 4 minutes. The resulting supernatant was removed and discarded. The remaining pellet was
resuspended in 1 ml Hibernate EB™ solution (2% B27 and 0.5 mM Glutamax).
A 20 µl aliquot of the cells was transferred into a microcentrifuge tube containing a 20 µl
aliquot of 0.4% typan blue and were mixed and counted via use of a hemocytometer. The cells
were then diluted in preparation for plating ~1500 – 2000 cells/well. The cells were then seeded
for culture on previously prepared Poly-D-Lysine coverslips. The cells were incubated for a total
of 14 days in a humid 37°C CO2 incubator. Neurobasal medium (Hibernate EB solution™) and
cytosine β-D-arabinofuranoside was added to each cultured coverslip every 2 days.
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Permeabilization and Blocking
Coverslips of neuronal cell culture were chosen to be permeabilized at a schedule of two
every two days in an effort to observe and analyze cell cultures arrested at different points of
time during growth. Each coverslip was washed with PBS buffer three times, with each wash
lasting approximately 5 minutes. An aliquot of dissolved 0.3 % Triton X-100 in PBS buffer
solution was then added to each coverslip. The cells were then permeabilized in this solution for
5 minutes. The 5 minute PBS buffer wash was then performed three more times following
permeabilization. Cells were finally blocked in PBS containing 1% for 1 hour at 25°C.
Primary Antibody Solution
Anti-Beta-III-Tubulin 1° mouse antibody was diluted by a 1:200 dilution in PBS
containing 1% BSA according to the following calculation: 1 μl: 200 μl 1% BSA/PBS. This 1°
antibody solution was stored on ice. A small glass slab was obtained and covered in Parafilm
secured with tape. Two 50 μl aliquots of 1° antibody were aliquoted on isolated areas of the
Parafilm-covered glass slab. Follwing the 1 hour blocking period, coverslips were carefully
removed from the solution via forceps and gently inverted (cell side down) over each 1° antibody
aliquot (carefully, as to not create any air bubbles under the coverslip. The whole glass slab was
then covered with another sheet of Parafilm, and coverslips were incubated in 1° antibody at 4°C
overnight.
Secondary Antibody Solution
Following incubation of cells in diluted primary antibody solution, the Parafilm was
removed from the glass slab setup and coverslips were gently placed into a clean cell culture
plate via forceps. The coverslips were washed in PBS buffer three times, with each wash lasting
approximately 5 minutes. A 1:10 dilution of anti-mouse 2° antibody (anti-mouse IgG conjugated
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to Alexa Fluor 488) was further diluted according to the following: 7 μl 2° antibody: 4 ml PBS
containing 1% BSA. Two ml of the diluted 2° antibody was applied to each coverslip in separate
wells for 2 hours at 25°C. The cell-culture plate was covered in aluminum foil so as to allow
incubation to occur in the dark. Following the 2 hour incubation in diluted 2° antibody, the
solution was removed and added to waste. The coverslips were then washed in PBS buffer three
times, with each wash lasting approximately 5 minutes. Washes were performed under the
aluminum foil to prevent 2° antibody light overexposure.
Nuclear Staining
Coverslips were then incubated in 3 µl 4',6-diamidino-2-phenylindole nuclear
counterstain (DAPI) for 1 minute. Each coverslip was again washed with PBS buffer for 5
minutes.
Mounting for Visualization
Glass microscope slides were obtained upon time for fluorescent microscopy analysis.
Coverslips were inverted over the glass microscope slide with use of forceps, carefully as to
reduce the appearance of any air bubbles under the coverslip. The coverslips were adhered to the
glass slide via a small amount of clear nail lacquer. Microscope slides that were fixed were
allowed to dry overnight at 4 °C in the dark before being analyzed via microscopy.
Slides were observed and analyzed for neurite outgrowth via fluorescent microscopy on a
Nikon Eclipse 80/X-cite Series 120 microscope equipped with a digital camera. For each
microscope slide, digital photos were taken of ten randomly chosen microscope frames. Three
sets of photos were taken for each randomly chosen frame- one under bright white light, one
under blue fluorescent light for the illumination of anti-Neuron specific beta III Tubulin, and one
under fluorescent green light for the illumination of DAPI-stained cell nuclei.
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Fluorescent Microscopy Analysis
Digital photos were analyzed via NIS-Elements BR 3.2 computer programming, and two
sets of cell counts were taken for each microscope slide: a count of the total number of cells, and
a count of the total number of differentiated cells. Cells were considered differentiated if they
exhibited evidence of a developing soma at least twice the nucleus diameter, and/or visible
neurite outgrowth. For each slide, a percentage of cells differentiated was calculated.

Results
The mouse neocortical cells were treated with Hibernate EB™ solution and cytosine β-Darabinofuranoside, and were cultured for a total of 14 days. For every two days of culture, cells
were arrested at different periods of growth and fixed to microscopes slides for visualization and
cell counting. Neocortical cells which displayed a small, standard round shape, within which a
cell nucleus was visible, were considered undifferentiated. Those neocortical cells that were
fixed and observed at the beginning of the cell culture timeline remained significantly
undifferentiated, and were observed to display nothing more than cell nuclei (Figure 1).
Neocortical cells that were observed to have differentiated into neuronal cells demonstrated a
cell body with a minimum diameter of double the cell’s nucleus, observable neurite outgrowth of
axonal cytoskeletons, and/or the formation of filapodia-like projections (Figure 2).
In observation of the morphology of the undifferentiated mouse neocortical cells into
neuronal structures, a clear development of the undifferentiated neocortical cells into the
formation of neurons can be observed (Figure 3). At day two of the cell culture, cells remained
significantly undifferentiated, and only cell nuclei were present (Figure 3A). During day four of
culture, the appearance of cell bodies were evident, and most of those observed were at least
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double the cell nucleus in size (Figure 3B). Day six of culture yielded cells that demonstrated
cell bodies with a slight increase in size, demonstrating an increase in cell growth with the
progression of time (Figure 3C). At eight days of culture, the beginnings of neuronal class III βtubulin microtubule elements were observed as illuminated by the fluorescein-labeled 2° antimouse antibodies tagging the β-III tubulin of the developing neurons (Figure 3D). By 10 days of
culture, the differentiating cells displayed evidence of developing neurite outgrowth of axonal
cytoskeletons (Figure 3E). The observation of the microtubule elements at 12 days of
differentiation revealed a display of a more wispy appearance of its developing neuronal
cytoskeleton; these wispy elements resembled the formation of filopodia-like projections (Figure
3F). At 14 days of differentiation in cell culture, a large majority of the cells were observed to
have formed into semi-mature neurons, with observable somas, axons, and the beginnings of
dendritic elements (Figure 3G).
Neocortical cells that were observed to have an absolute bare minimum of differentiated
were those that had been cultured for the least amount of time in the 14- day cell culture time
frame; these cells were arrested at two days of growth. Out of the 202 total cells that were
counted by their cell nuclei, only eight cells were considered to display cell bodies that were at
least twice the diameter of their cell nuclei. These eight cells were thus considered to
demonstrate the beginnings of cell differentiation, making up a mere 4% percent differentiation
at two days of culture (Table 1). Neocortical cells that were observed to demonstrate a maximum
percentage of differentiation during the 14-day cell culture were those that had been cultured for
14 days. There were 236 total cells that had been counted from the randomly-selected 10 frames
of reference from this fixed microscope slide. Of this total cell count, 153 cells were determined
to have demonstrated differentiation into neuronal cells. For the end of the current study’s 14-
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day cell culture, the maximum percent differentiation of cells into neurons for this culture was
represented by a percentage of 64.8% (Table 1).
In observation of the morphology of the neocortical cells from the current study’s 14-day
culture into neurons, the percent differentiation of cells into neurons was observed to increase
over time (Figure 4).

Figure 1: Structure of Undifferentiated Mouse Neocortical Cells. Photos were taken at 40x
magnifications following the first two days of cell culture. At the time of photography, cells were
visualized under (A) white light, (B) blue fluorescent light, illuminating fluorescein-labeled 2° antibody,
tagging beta III Tubulin, and (C) green fluorescent light, illuminating cell nuclei stained with DAPI
nuclear counterstain. Photo (D) is a representation of the 2 day-old undifferentiated cells composed via
superimposing photos (B) and (C).
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Figure 2: Structure of Differentiated Mouse Neocortical Cells. Photos were taken at 40x
magnifications following 14 days of cell culture. At the time of photography, cells were visualized under
(A) white light, (B) blue fluorescent light, illuminating fluorescein-labeled 2° antibody, tagging beta III
Tubulin, and (C) green fluorescent light, illuminating cell nuclei stained with DAPI nuclear counterstain.
Photo (D) is a representation of the 14 day-old differentiated cells composed via superimposing photos
(B) and (C).
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Figure 3: Morphology of Mouse Neocortical Cells Treated with Hibernate EB™ solution and
Cytosine β-D-Arabinofuranoside over Time. Photos were taken at 40x magnifications under blue
fluorescent light, illuminating fluorescein-labeled 2° antibody, tagging beta III Tubulin in differentiating
neurons. At the time of visualization and photography, cells had been cultured for (A) 2 days, (B) 4 days,
(C) 6 days, (D) 8 days, (E) 10 days, (F) 12 days, and (G) 14 days.
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Table 1: Percent Differentiation of Mouse Neocortical Cells into Neurons over a 14-Day Timeline.

Day of Culture
2

Total Number
of Cells
202

Number of
Differentiated Cells
8

Percent
Differentiation
4.0%

4

203

40

19.7%

6

161

32

19.9%

8

221

71

32.1%

10

225

75

33.3%

12

234

117

50.0%

14

236

153

64.8%

Cells were removed from culture and fixed for visualization via fluorescent microscopy at two-day
intervals over a 14-day timeline. A total cell count via illumination of cell nuclei, and a count of the total
number of differentiated cells were taken from 10 frames of each microscope slide magnified at 100x. A
percentage of differentiated cells was then calculated for each slide. Percent differentiation of cells for
every two days of culture is displayed in the table above.

Percent of Cells Differentiated

100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
0

2

4

6

8

10

12

14

Time (Days)
Figure 4: Percent Differentiation of Mouse Neocortical Cells over Time. Displays a plot of the percent
of neocortical cells differentiated into neurons over time (days). The percent differentiation was
considered over a culture timeline of 14 days.
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Discussion
Pyrethroids are synthetic pesticides that can be found almost everywhere today. What
may be most surprising to the general public worldwide is that these chemicals can be found in
schools and restaurants, in mosquito-abatement programs, on livestock, and in the majority of
households amongst products that many people utilize daily: roach, ant, and flying insect spray;
flea bombs; roach traps and baits; pet tick-and-flea collars and shampoos; and lice and scabies
shampoos for humans (Agency for Toxic Substances and Disease Registry, 2003). It is also
possible for people to ingest pyrethroids through the eating of conventionally-grown fruits and
vegetables (Agency for Toxic Substances and Disease Registry, 2003). With the potential for
people and mammalian animals alike to encounter these chemicals from a variety of sources of
daily lifestyle, mammals may become exposed to pyrethroids through a variety of sources in
daily lifestyle, via: the spraying of a product that can be used to kill flies or roaches, the
accidental ingestion of the chemicals after getting them on skin or food, or the absorption of the
chemicals through the skin while bathing a pet or from lice shampoos.
With pyrethroid chemicals being encountered by most people from day to day, the acute
toxicity of pyrethroids to adults has been investigated, and the U.S. Environmental Protection
Agency has documented them as moderately toxic (EPA Category II) to mammals (Soderlund et
al., 2002). However, despite the abundance of this information on acute neurotoxicity to adult
mammals, there is little to no evidence regarding the potential neurotoxicity effects of the
chemicals on the development of mammals. In fact, the “Toxicological Profile for Pyrethrins and
Pyrethroids” published by the Center for Disease Control and Prevention has a specific heading
for “Developmental Effects” on human health caused by exposure to pyrethroids. This document
is blank under the heading of “Developmental Effects”, indicating that there is not yet any
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evidence on whether or not pyrethroid exposure has the potential to cause harmful
neurodevelopmental effects (Centers for Disease Control and Prevention, 2003).
Further, the official document, “Safety of Pyrethroids for Public Health Use” published
by the World Health Organization (WHO) has a specific heading which attempts to address the
“Neurodevelopmental Effects” of pyrethroid exposure; however, the evidence of very few
studies is presented under this heading, indicative that very few studies that aim to address this
concern have been conducted at all (World Health Organization, 2005). The result of a 1991
study conducted in Sweden was amongst one of the few posted by the WHO under the heading
of “Neurodevelopmental Effects”. This study that was conducted on neonatal mice concluded
that oral administration of deltamethrin (0.7 mg/kg bw/day by gavage in a sonicated mixture of
egg lecithin, peanut oil and water on seven consecutive days) during rapid brain growth
(postnatal days 10–16) induced changes in the density of muscarinic cholinergic receptors in the
brain shortly after exposure, (this effect was also observed in adult animals treated in the
neonatal period (Eriksson and Fredricksson, 1990). In addition, the animals were observed to
demonstrate choreoatetotic symptoms at only a slightly higher dose (1.2 mg/kg bw) (Eriksson
and Fredricksson, 1990). The World Health Organization utilized the evidence of this study to
demonstrate that there can be possible detrimental neurodevelopmental effects on developing
young. However, in further reflection of these results, the WHO considers the quantitative
interpretation of these findings to human health unclear due to the particular administration
procedure used in the study.
Another study that may highlight the potential for developmental neurotoxicity due to
pyrethroid exposure concerned Mexican children whom had been exposed to a mixture of
agricultural pyrethroids that had been used for agricultural purposes during their development.

Page 17 of 26

Savino
The observations of this study revealed that these children had adverse effects on motor skills,
memory, attention, and learning (Guillette, et al., 1998). There is potential that the pyrethroids
may have been the causal link between the children and the development of their adverse effects;
however, this study proved to be a very limited one, and further investigation is necessary
(Schettler, 2001).
Two additional studies concerning the pyrethroid deltamethrin demonstrated that:
exposure to this pesticide has the potential to induce apoptosis in cultured mouse cerebral
cortical neurons (Wu et al., 2003), and that low-level in utero exposure of embryonic rats to
deltamethrin has to potential to cause increased hippocampal acetycholinesterase activity and
decreased learning and memory between the six to twelve weeks of the postnatal period (Aziz et
al., 2001).
The studies such as those mentioned above are only some of the few which have
attempted to investigate into the dangerous developmental neurotoxicity effects of pyrethroids.
With only a very limited amount of studies available, with some of which that have since been
considered “unclear” or “limited” in regards to human health, there is a necessity for further
studies to be conducted. The European Union (EU) has begun to raise concern regarding
potential neurodevelopmental effects of pyrethroids (Lautraite and Sargent, 2009). It is time to
begin to provide the regulatory agencies in North America and the EU with conclusive research
on this topic (Lautraite and Sargent, 2009).
In a 2006 study conducted by the Department of Biology at Adelphi University, the
potential deleterious effects on neurite outgrowth of cultured PC12 cells were investigated in an
attempt to address the possible toxicological effects of bifenthrin, one of the newest additions to
the synthetic pyrethroid insecticides that has exhibited a wider range of insecticidal properties
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than previous pyrethroids (Tran et al., 2006), on neuronal development. With this assessment, the
scientists hoped to address the potential consequences of maternal exposure to pyrethroids on the
developing nervous system of mammalian young.
The study utilized rat PC12 cells of the neuronal cell line to assess whether bifenthrin
affected viability of the PC12 cells and the neurite outgrowth of the cells when seeded in nerve
growth factor. The viability of the PC12 cells given the control treatment was 100%. Technical
grade bifenthrin was not found to be toxic to PC12 cells at a concentration of 10–3 M, which was
the highest soluble concentration of bifenthrin tested; cell viability was determined to fluctuate
around 110% for cultures of 72 and 96 hours, and be greater than 120% for 24 hour cultures
(Tran et al., 2006). In terms of neurite outgrowth, the percentage of cells with neurites observed
in the control cells after 48 hours of treatment was considered to be 110%. The concentrations of
technical grade bifenthrin observed to inhibit neurite outgrowth by approximately 35% and 75%
after 48 hours of treatment were 10–6 M and 10–3 M (Tran et al., 2006).
In analyzing these findings, it was determined that the technical grade bifenthrin had
detrimental effects on neurite formation at concentrations of bifenthrin which prove to have no
effect on actual cell viability. Since bifenthrin has previously been classified as a moderate
hazard by the WHO and therefore, has been considered safe for household use, it is no surprise
that cell viability was not affected. However, in considering the effects of bifenthrin on neurite
outgrowth of developing cells in the absence of cell death, the perceived advantageous use of this
pesticide may not be as ideal as previously determined, even at levels of low toxicity.
The results of this study suggest that bifenthrin and other pyrethroids may have a
significant and detrimental effect on the developing nervous system, in the absence of
determined toxicity. Exposure of a mammalian maternal system to these pyrethroids may not

Page 19 of 26

Savino
elicit immediate lethal effects on the adult, but may induce gradual tissue degeneration of the
reproductive system (Tran, et al., 2006). Exposure to levels of pyrethroids that have previously
been determined “safe” for a mammalian adult may actually lead to eventual
neurodevelopmental abnormalities and defects of prenatal young exposed to degenerated utero
tissues.
The abovementioned study asserts crucial theories on the potentially detrimental effects
of pyrethroids on developing mammalian young; however, further investigation with additional
study is necessary to support these assumptions and conclusions. Just as the abovementioned
study aimed to develop a neurodevelopment assay of cultured PC12 cells to assess the
neurodevelopmental effects of pyrethroids, the purpose of the current study is develop an assay
of cultured neuronal cells, which might be used in the future to similarly assess the
neurodevelopmental effects of pyrethroids. With the development of an assay that utilizes
neurons, the detrimental effects of pyrethroids on developing neurons can provide more accurate
conclusions on the neurodevelopmental effects of these pesticides. This study is essentially the
first step in working toward establishing such an assay.
The current study aims to demonstrate the necessity of a neurodevelopmental assay in
order for further investigation into the potential of pyrethroids to cause developmental effects on
developing mammalian neurons. This assay allows for the monitoring of the development of
neurons in cell culture, in preparation for the evaluation of the effects of pyrethroids on
developing neurons. The benefits of using a cell culture and neurodevelopmental assay to
prepare for the evaluation of the pyrethroids proves to be a cheaper, more time-efficient method
in collecting experimental results (National Research Council of the National Academies, 2003),
and it is an experimental method that can be considered highly ethical, as well. The use of an
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efficient, reliable neuronal culture can spare the lives of over laboratory rodents, in addition to
sparing the expenses of scientists. For these reasons, the neurodevelopmental assay developed in
the current study as opposed to the more traditional method of utilizing whole animals will prove
most efficient and effective in the next step of this project- evaluating the neurodevelopmental
effects of pyrethroids.
The assay that had been developed in this study established a timeline for maximum cell
differentiation of the mouse neocortical cells into neurons during a 14-day cell culture. In
addition, parameters for defining whether or not a cell was considered differentiated were also
determined. Mouse neocortical cells that were fixed and observed at the beginning of the cell
culture timeline remained significantly undifferentiated, and were observed to display nothing
more than cell nuclei (Figure 1). Neocortical cells that were observed to have differentiated into
neuronal cells demonstrated a cell body with a minimum diameter of double the cell’s nucleus,
observable neurite outgrowth of axonal cytoskeletons, and/or the formation of filopodia-like
projections (Figure 2). Although the appearance of cell bodies were evident, and most were at
least double the cell nucleus in size (Figure 3B) by day four of culture, the beginnings of
neuronal class III β-tubulin microtubule elements were not observed until day eight of culture
(Figure 3D). By 10 days of culture, the differentiating cells displayed evidence of developing
neurite outgrowth of axonal cytoskeletons (Figure 3E) and by day 12 of culture, the formation of
filopodia of the developing neurons were observed (Figure 3F).
At 14 days of differentiation in cell culture, a large majority of the cells were observed to
have formed into semi-mature neurons, with observable somas, axons, and the beginnings of
dendritic elements (Figure 3G). These neocortical cells that had been cultured for 14 days also
displayed a maximum amount of differentiation into neurons for this particular 14-day cell
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culture. For the end of the current study’s 14-day cell culture, the maximum percent
differentiation of cells into neurons for this culture was represented by a percentage of 64.8%
(Table 1).
The fact that ~65% of the neocortical cells had demonstrated differentiation into neurons
at day 14 of the culture does support the preliminary hypothesis that maximum differentiation
will be at day 14 of the culture; however, since only ~65% of cells had differentiated at day 14, it
may be that a culture with a timeline longer than 14 days should be conducted in order to
establish an assay with 100% differentiation, and to determine a new timeline for this culture. In
observation of the morphology of the neocortical cells from the current study’s 14-day culture
into neurons, the percent differentiation of cells into neurons was observed to increase over time
(Figure 4). With this observation with a direct relationship between differentiation and time, it
can be hypothesized that the cells would continue to differentiate in greater calculated
percentages with an increase in time for a culture to progress, beyond the 14 days of the present
study.
In reflecting upon the results of the current study, it can be concluded that the second part
of the preliminary hypothesis, which predicted that cell differentiation into neurons would begin
at day 10 of the culture, was not very far off. The current study defined differentiation of a cell
into a neuron as a cell body with a minimum diameter of double the cell’s nucleus, observable
neurite outgrowth of axonal cytoskeletons, and/or the formation of filapodia-like projections
(Figure 2). During day four of culture, the appearance of cell bodies were evident, and most of
those observed were at least double the cell nucleus in size (Figure 3B); therefore, the current
study considered these cells as being differentiated. However, in defining cell differentiation by
visible evidence of developing neurite outgrowth of axonal cytoskeletons, as the studies in the
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primary literature do (Tran et al., 2006), then this observation was seen by day 10 of culture,
(Figure 3E), and these results do support the preliminary hypothesis.
In the 2006 study conducted by the Department of Biology at Adelphi University, where
PC12 cells were stimulated with Nerve Growth Factor, a 100% maximum differentiation of the
cells into pseudo-neuronal cells was observed after 48 hours of culture. In analyzing these results
with the results of the current study, where only a 4% differentiation rate was observed,
questions arise concerning such a large inconsistency in results. These concerns might be
addressed with the following considerations: Tran et al., 2006 utilized rat PC12 cells which were
stimulating to grow neurites to resemble neurons, while the current study cultured mouse
neonatal neuronal cells; Tran et al., 2006 utilized Nerve Growth Factor to stimulate the PC12
cells to grow neurites, while the current study utilized Hibernate EB™ solution (2% B27 and 0.5
mM Glutamax).
The 2006 study conducted at Adelphi University found that bifenthrin does inhibit neurite
formation in the absence of cell death on PC12 cells differentiating into pseudo-neuronal cells
(Tran et al., 2006). In reflection of the results of this study, the following conclusions and
considerations have been made: that bifenthrin exposure in utero has the potential to lead to
neurodevelopmental defects, and that chronic exposure to bifenthrin may lead to
neurodegenerative disease (Tran et al., 2006). Therefore, with the wide use of bifenthrin as a
pesticide with a great selective toxicity to insects, the determined “safe use” of this particular
pesticide should be scrutinized. In addition, these results received from a study which utilized
bifenthrin might cause one to scrutinize the use of all other pyrethroids as well, until their effects
on developmental neurotoxicity are proved harmless.
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In contrast to the 2006 study conducted at Adelphi University, which aimed to investigate
the potential developmental neurotoxicity effects of the pyrethroid bifenthrin (Tran et al., 2006),
the current study aims to establish the beginnings of a reliable assay where the potential
developmental effects of pyrethroids could be assessed on actual developing neurons.
In preparation for future studies, a first step would be to either evaluate a neuronal culture
with a longer timeline, or to culture cells according to the 14-day timeline of the current study,
but to utilize a fresher, or different neuron nutrient medium in an attempt to encourage a greater
maximum differentiation at an earlier point in the culture. In developing the next cell culture,
consideration should be taken in ensuring more accurate results by: performing maximum
differentiation calculations in duplicate for each day of culture being evaluated, and having a
negative experimental control for DAPI nuclear counterstain of cells only.
A next step might be to perform the actual assay by adding a pyrethroid to the developing
cells: first, at a time of little to no cell differentiation at the earliest days of the culture, and then
at the day of culture determined to demonstrate maximum cell differentiation (for the current
study, at day 14 [Table 1]). The chosen pyrethroid should then be applied in differing
concentrations of strength to determine if the treatments inhibit or discourage cell differentiation,
at all; and if so, at which concentrations, so that a dose-responses curve might be created. A
long-term future goal would be to repeat the experiment with multiple pyrethroids first in one
class, and then moving on to another.
As mentioned earlier, the official document entitled “Safety of Pyrethroids for Public
Health Use” published by the World Health Organization has little information on the topic of
“Neurodevelopmental Effects” of pyrethroids (World Health Organization, 2005). In addition,
the document entitled “Toxicological Profile for Pyrethrins and Pyrethroids” published by the
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Center for Disease Control and Prevention has absolutely no information under the heading of
“Developmental Effects” (Centers for Disease Control and Prevention, 2003). This study is one
small step that attempts to prepare to address one potentially very large, yet silent issue.
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